Article Versions Notes

Molina P, Molina MD, Carrero JJ, Escudero V, Torralba J, Castro-Alonso C, Beltrán S, Vizcaíno B, González-Moya M, Kanter J, et al. Sevelamer Use and Mortality in People with Chronic Kidney Disease Stages 4 and 5 Not on Dialysis. Journal of Clinical Medicine. 2023; 12(24):7631. https://doi.org/10.3390/jcm12247631

Molina, Pablo, Mariola D. Molina, Juan J. Carrero, Verónica Escudero, Javier Torralba, Cristina Castro-Alonso, Sandra Beltrán, Belén Vizcaíno, Mercedes González-Moya, Julia Kanter, and et al. 2023. "Sevelamer Use and Mortality in People with Chronic Kidney Disease Stages 4 and 5 Not on Dialysis" Journal of Clinical Medicine 12, no. 24: 7631. https://doi.org/10.3390/jcm12247631

Molina, P., Molina, M. D., Carrero, J. J., Escudero, V., Torralba, J., Castro-Alonso, C., Beltrán, S., Vizcaíno, B., González-Moya, M., Kanter, J., Sancho-Calabuig, A., Bover, J., & Górriz, J. L. (2023). Sevelamer Use and Mortality in People with Chronic Kidney Disease Stages 4 and 5 Not on Dialysis. Journal of Clinical Medicine, 12(24), 7631. https://doi.org/10.3390/jcm12247631